Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
March 8, 2022
Patent Application Number
16753307
Date Filed
October 5, 2018
Patent Citations
Patent Primary Examiner
Patent abstract
The invention provides antibodies that specifically bind to transthyretin (TTR). The antibodies can be used for treating or effecting prophylaxis of diseases or disorders associated with TTR accumulation or accumulation of TTR deposits (e.g., TTR amyloidosis). The antibodies can also be used for diagnosing TTR amyloidosis and inhibiting or reducing aggregation of TTR, and for monitoring the efficacy of TTR therapies, among other applications.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
